Initial Treatment of Idiopathic Nephrotic Syndrome in Children with Mycophenolate Mofetil vs. Prednisone: A Prospective, Randomized, Controlled, Multicenter, Open, Phase 3, Noninferiority Study

被引：0
|
作者：
Benz, Marcus R. [1 ,2 ]
Ehren, Rasmus [1 ]
Hoecker, Britta [3 ]
Fichtner, Alexander [3 ]
Querfeld, Uwe [4 ]
Hoyer, Peter F. [5 ]
Kemper, Markus J. [6 ]
Haffner, Dieter [7 ]
Dotsch, Joerg [1 ]
Konrad, Martin [8 ]
Sander, Anja Christine [9 ]
Meis, Jan [9 ]
Toenshoff, Burkhard [3 ]
Weber, Lutz Thorsten [1 ]
机构：
[1] Univ Hosp Cologne, Cologne, Germany
[2] Pediat Nephrol Dachau, Dachau, Germany
[3] Univ Childrens Hosp Heidelberg, Heidelberg, Germany
[4] Charite Univ Med Berlin, Berlin, Germany
[5] Univ Duisburg Essen, Duisburg, Nordrhein Westf, Germany
[6] Asklepios Kliniken GmbH & Co KGaA, Hamburg, Germany
[7] Med Hsch Hannover Zentrum Kinderheilkunde & Jugen, Hannover, Niedersachsen, Germany
[8] Univ Munster, Munster, Nordrhein Westf, Germany
[9] Heidelberg Univ, Heidelberg, Baden Wurttembe, Germany
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024dxr49rap
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-OR74
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
    Tomoko Horinouchi
    Mayumi Sako
    Koichi Nakanishi
    Kenji Ishikura
    Shuichi Ito
    Hidefumi Nakamura
    Mari Saito Oba
    Kandai Nozu
    Kazumoto Iijima
    BMC Nephrology, 19
  • [22] Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JS']JSKDC07)
    Horinouchi, Tomoko
    Sako, Mayumi
    Nakanishi, Koichi
    Ishikura, Kenji
    Ito, Shuichi
    Nakamura, Hidefumi
    Oba, Mari Saito
    Nozu, Kandai
    Iijima, Kazumoto
    BMC NEPHROLOGY, 2018, 19
  • [23] Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study
    Sohn, W.
    Lee, O. Y.
    Kwon, J. G.
    Park, K. S.
    Lim, Y. J.
    Kim, T. H.
    Jung, S. W.
    Kim, J. I.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (09): : 860 - +
  • [24] N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study
    Elnashar, Aboubakr
    Fahmy, Mohi
    Mansour, Ahmad
    Ibrahim, Karima
    FERTILITY AND STERILITY, 2007, 88 (02) : 406 - 409
  • [25] A prospective, randomized, double blind multicenter study of early (7 day) corticosteroid cessation vs. long term low dose corticosteroid therapy under tacrolimus and mycophenolate mofetil therapy with antibody induction in renal transplant recipients
    Woodle, ES
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 578 - 578
  • [26] Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study
    Hook, Edward W., III
    Golden, Matthew R.
    Taylor, Stephanie N.
    Henry, Eugenia
    Tseng, Carol
    Workowski, Kimberly A.
    Swerdlow, Terri
    Nenninger, Ashley
    Cammarata, Sue
    SEXUALLY TRANSMITTED DISEASES, 2019, 46 (05) : 279 - 286
  • [27] The HELENA study: Hexvix®-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy—a prospective randomized controlled open-label multicenter non-inferiority study
    M. Gierth
    J. Breyer
    F. Zeman
    H. M. Fritsche
    J. Cordes
    A. Karl
    D. Zaak
    A. Stenzl
    I. Kausch von Schmeling
    A. Sommerhuber
    T. Zierer
    M. Burger
    R. Mayr
    World Journal of Urology, 2021, 39 : 3799 - 3805
  • [28] The HELENA study: Hexvix®TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy-a prospective randomized controlled open-label multicenter non-inferiority study
    Gierth, M.
    Breyer, J.
    Zeman, F.
    Fritsche, H. M.
    Cordes, J.
    Karl, A.
    Zaak, D.
    Stenzl, A.
    von Schmeling, I. Kausch
    Sommerhuber, A.
    Zierer, T.
    Burger, M.
    Mayr, R.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (10) : 3799 - 3805
  • [29] COMPARISON OF INTRALESIONAL HYALURONIC ACID VS. VERAPAMIL FOR THE TREATMENT OF ACUTE PHASE PEYRONIE'S DISEASE: A PROSPECTIVE, OPEN-LABEL NON-RANDOMIZED CLINICAL STUDY
    Cocci, A.
    Di Maida, F.
    Cito, G.
    Campi, R.
    Tellini, R.
    Mari, A.
    Di Mauro, M.
    Falcone, M.
    Capece, M.
    Romano, A.
    Di Costanzo, R.
    Verrienti, P.
    Garaffa, G.
    Mondaini, N.
    Minervini, A.
    Russo, G., I
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S135 - S136
  • [30] Comparison of Intralesional Hyaluronic Acid vs. Verapamil for the Treatment of Acute Phase Peyronie's Disease: A Prospective, Open-Label Non-Randomized Clinical Study
    Cocci, Andrea
    Di Maida, Fabrizio
    Cito, Gianmartin
    Verrienti, Pierangelo
    Laruccia, Nicola
    Campi, Riccardo
    Mari, Andrea
    Di Mauro, Marina
    Falcone, Marco
    Cacciamani, Giovanni E.
    Garaffa, Giulio
    Minervini, Andrea
    Russo, Giorgio Ivan
    WORLD JOURNAL OF MENS HEALTH, 2021, 39 (02): : 352 - 357
12345